Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging

Background and purpose The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data. Methods Upper girdle and/or lower limb muscle magnetic resonance imaging scans o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of neurology 2020-12, Vol.27 (12), p.2604-2615
Hauptverfasser: Giacomucci, G., Monforte, M., Diaz‐Manera, J., Mul, K., Fernandez Torrón, R., Maggi, L., Marini Bettolo, C., Dahlqvist, J. R., Haberlova, J., Camaño, P., Gros, M., Tartaglione, T., Cristiano, L., Gerevini, S., Calandra, P., Deidda, G., Giardina, E., Sacconi, S., Straub, V., Vissing, J., Van Engelen, B., Ricci, E., Tasca, G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2615
container_issue 12
container_start_page 2604
container_title European journal of neurology
container_volume 27
creator Giacomucci, G.
Monforte, M.
Diaz‐Manera, J.
Mul, K.
Fernandez Torrón, R.
Maggi, L.
Marini Bettolo, C.
Dahlqvist, J. R.
Haberlova, J.
Camaño, P.
Gros, M.
Tartaglione, T.
Cristiano, L.
Gerevini, S.
Calandra, P.
Deidda, G.
Giardina, E.
Sacconi, S.
Straub, V.
Vissing, J.
Van Engelen, B.
Ricci, E.
Tasca, G.
description Background and purpose The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data. Methods Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1‐weighted and short‐tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema. Results The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro‐caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2. Conclusion This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD‐related disease spectrum.
doi_str_mv 10.1111/ene.14446
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2426535864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2458467735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-dd37ce869fd0a5e5240d7d22489bc38309347aa3d4a00507a7b4fde8a1e234533</originalsourceid><addsrcrecordid>eNp1kMtKxDAUhoMoXkYXvoAE3OiiTu7pLEXHCwy60XXIJKdOpW1qMkX69kZHXQieTQ7hy8efH6FjSi5onil0cEGFEGoL7VOhyoJyTrfzziUtJCV0Dx2k9EoIYZqRXbTHmZrpUvF9ZK4BetyvoAvrsa-7FxwqXFlXh-RsPzRhNbQQbYPbIbmhsRH7Ma1j6Fcjzg8AM7wccWtfOljXDkdIobOdA1znu6w7RDuVbRIcfZ8T9Hwzf7q6KxaPt_dXl4vCcclV4T3XDko1qzyxEiQTxGvPmChnS8dLTmZcaGu5F5YQSbTVS1F5KC0FxoXkfILONt4-hrcB0tq0dXLQNLaDMCTDBFOSy1KJjJ7-QV_DELucLlOyFErrnGmCzjeUiyGlCJXpY_5THA0l5rN1k1s3X61n9uTbOCxb8L_kT80ZmG6A97qB8X-TmT_MN8oP7RCLtQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2458467735</pqid></control><display><type>article</type><title>Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging</title><source>Wiley Journals</source><creator>Giacomucci, G. ; Monforte, M. ; Diaz‐Manera, J. ; Mul, K. ; Fernandez Torrón, R. ; Maggi, L. ; Marini Bettolo, C. ; Dahlqvist, J. R. ; Haberlova, J. ; Camaño, P. ; Gros, M. ; Tartaglione, T. ; Cristiano, L. ; Gerevini, S. ; Calandra, P. ; Deidda, G. ; Giardina, E. ; Sacconi, S. ; Straub, V. ; Vissing, J. ; Van Engelen, B. ; Ricci, E. ; Tasca, G.</creator><creatorcontrib>Giacomucci, G. ; Monforte, M. ; Diaz‐Manera, J. ; Mul, K. ; Fernandez Torrón, R. ; Maggi, L. ; Marini Bettolo, C. ; Dahlqvist, J. R. ; Haberlova, J. ; Camaño, P. ; Gros, M. ; Tartaglione, T. ; Cristiano, L. ; Gerevini, S. ; Calandra, P. ; Deidda, G. ; Giardina, E. ; Sacconi, S. ; Straub, V. ; Vissing, J. ; Van Engelen, B. ; Ricci, E. ; Tasca, G.</creatorcontrib><description>Background and purpose The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data. Methods Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1‐weighted and short‐tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema. Results The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro‐caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2. Conclusion This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD‐related disease spectrum.</description><identifier>ISSN: 1351-5101</identifier><identifier>EISSN: 1468-1331</identifier><identifier>DOI: 10.1111/ene.14446</identifier><identifier>PMID: 32697863</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Dystrophy ; Edema ; facioscapulohumeral muscular dystrophy ; FSHD ; FSHD2 ; Limbs ; Magnetic resonance imaging ; Medical imaging ; muscle MRI ; Muscles ; Muscular dystrophy ; neuromuscular diseases ; Phenotyping ; Resonance ; Tau protein</subject><ispartof>European journal of neurology, 2020-12, Vol.27 (12), p.2604-2615</ispartof><rights>2020 European Academy of Neurology</rights><rights>2020 European Academy of Neurology.</rights><rights>Copyright © 2020 European Academy of Neurology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-dd37ce869fd0a5e5240d7d22489bc38309347aa3d4a00507a7b4fde8a1e234533</citedby><cites>FETCH-LOGICAL-c3536-dd37ce869fd0a5e5240d7d22489bc38309347aa3d4a00507a7b4fde8a1e234533</cites><orcidid>0000-0001-9867-9047 ; 0000-0001-6144-8544 ; 0000-0003-2941-7988 ; 0000-0002-4327-6969 ; 0000-0003-3092-3597 ; 0000-0002-8711-331X ; 0000-0002-0828-5800 ; 0000-0001-8487-9478 ; 0000-0002-2741-5009 ; 0000-0002-4116-5579 ; 0000-0002-3149-1661 ; 0000-0002-0246-1455 ; 0000-0003-3896-4078 ; 0000-0001-6948-876X ; 0000-0002-2374-194X ; 0000-0003-0849-9144 ; 0000-0001-9046-3540 ; 0000-0002-2202-8165</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fene.14446$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fene.14446$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32697863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giacomucci, G.</creatorcontrib><creatorcontrib>Monforte, M.</creatorcontrib><creatorcontrib>Diaz‐Manera, J.</creatorcontrib><creatorcontrib>Mul, K.</creatorcontrib><creatorcontrib>Fernandez Torrón, R.</creatorcontrib><creatorcontrib>Maggi, L.</creatorcontrib><creatorcontrib>Marini Bettolo, C.</creatorcontrib><creatorcontrib>Dahlqvist, J. R.</creatorcontrib><creatorcontrib>Haberlova, J.</creatorcontrib><creatorcontrib>Camaño, P.</creatorcontrib><creatorcontrib>Gros, M.</creatorcontrib><creatorcontrib>Tartaglione, T.</creatorcontrib><creatorcontrib>Cristiano, L.</creatorcontrib><creatorcontrib>Gerevini, S.</creatorcontrib><creatorcontrib>Calandra, P.</creatorcontrib><creatorcontrib>Deidda, G.</creatorcontrib><creatorcontrib>Giardina, E.</creatorcontrib><creatorcontrib>Sacconi, S.</creatorcontrib><creatorcontrib>Straub, V.</creatorcontrib><creatorcontrib>Vissing, J.</creatorcontrib><creatorcontrib>Van Engelen, B.</creatorcontrib><creatorcontrib>Ricci, E.</creatorcontrib><creatorcontrib>Tasca, G.</creatorcontrib><title>Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging</title><title>European journal of neurology</title><addtitle>Eur J Neurol</addtitle><description>Background and purpose The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data. Methods Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1‐weighted and short‐tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema. Results The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro‐caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2. Conclusion This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD‐related disease spectrum.</description><subject>Dystrophy</subject><subject>Edema</subject><subject>facioscapulohumeral muscular dystrophy</subject><subject>FSHD</subject><subject>FSHD2</subject><subject>Limbs</subject><subject>Magnetic resonance imaging</subject><subject>Medical imaging</subject><subject>muscle MRI</subject><subject>Muscles</subject><subject>Muscular dystrophy</subject><subject>neuromuscular diseases</subject><subject>Phenotyping</subject><subject>Resonance</subject><subject>Tau protein</subject><issn>1351-5101</issn><issn>1468-1331</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKxDAUhoMoXkYXvoAE3OiiTu7pLEXHCwy60XXIJKdOpW1qMkX69kZHXQieTQ7hy8efH6FjSi5onil0cEGFEGoL7VOhyoJyTrfzziUtJCV0Dx2k9EoIYZqRXbTHmZrpUvF9ZK4BetyvoAvrsa-7FxwqXFlXh-RsPzRhNbQQbYPbIbmhsRH7Ma1j6Fcjzg8AM7wccWtfOljXDkdIobOdA1znu6w7RDuVbRIcfZ8T9Hwzf7q6KxaPt_dXl4vCcclV4T3XDko1qzyxEiQTxGvPmChnS8dLTmZcaGu5F5YQSbTVS1F5KC0FxoXkfILONt4-hrcB0tq0dXLQNLaDMCTDBFOSy1KJjJ7-QV_DELucLlOyFErrnGmCzjeUiyGlCJXpY_5THA0l5rN1k1s3X61n9uTbOCxb8L_kT80ZmG6A97qB8X-TmT_MN8oP7RCLtQ</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Giacomucci, G.</creator><creator>Monforte, M.</creator><creator>Diaz‐Manera, J.</creator><creator>Mul, K.</creator><creator>Fernandez Torrón, R.</creator><creator>Maggi, L.</creator><creator>Marini Bettolo, C.</creator><creator>Dahlqvist, J. R.</creator><creator>Haberlova, J.</creator><creator>Camaño, P.</creator><creator>Gros, M.</creator><creator>Tartaglione, T.</creator><creator>Cristiano, L.</creator><creator>Gerevini, S.</creator><creator>Calandra, P.</creator><creator>Deidda, G.</creator><creator>Giardina, E.</creator><creator>Sacconi, S.</creator><creator>Straub, V.</creator><creator>Vissing, J.</creator><creator>Van Engelen, B.</creator><creator>Ricci, E.</creator><creator>Tasca, G.</creator><general>John Wiley &amp; Sons, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9867-9047</orcidid><orcidid>https://orcid.org/0000-0001-6144-8544</orcidid><orcidid>https://orcid.org/0000-0003-2941-7988</orcidid><orcidid>https://orcid.org/0000-0002-4327-6969</orcidid><orcidid>https://orcid.org/0000-0003-3092-3597</orcidid><orcidid>https://orcid.org/0000-0002-8711-331X</orcidid><orcidid>https://orcid.org/0000-0002-0828-5800</orcidid><orcidid>https://orcid.org/0000-0001-8487-9478</orcidid><orcidid>https://orcid.org/0000-0002-2741-5009</orcidid><orcidid>https://orcid.org/0000-0002-4116-5579</orcidid><orcidid>https://orcid.org/0000-0002-3149-1661</orcidid><orcidid>https://orcid.org/0000-0002-0246-1455</orcidid><orcidid>https://orcid.org/0000-0003-3896-4078</orcidid><orcidid>https://orcid.org/0000-0001-6948-876X</orcidid><orcidid>https://orcid.org/0000-0002-2374-194X</orcidid><orcidid>https://orcid.org/0000-0003-0849-9144</orcidid><orcidid>https://orcid.org/0000-0001-9046-3540</orcidid><orcidid>https://orcid.org/0000-0002-2202-8165</orcidid></search><sort><creationdate>202012</creationdate><title>Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging</title><author>Giacomucci, G. ; Monforte, M. ; Diaz‐Manera, J. ; Mul, K. ; Fernandez Torrón, R. ; Maggi, L. ; Marini Bettolo, C. ; Dahlqvist, J. R. ; Haberlova, J. ; Camaño, P. ; Gros, M. ; Tartaglione, T. ; Cristiano, L. ; Gerevini, S. ; Calandra, P. ; Deidda, G. ; Giardina, E. ; Sacconi, S. ; Straub, V. ; Vissing, J. ; Van Engelen, B. ; Ricci, E. ; Tasca, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-dd37ce869fd0a5e5240d7d22489bc38309347aa3d4a00507a7b4fde8a1e234533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Dystrophy</topic><topic>Edema</topic><topic>facioscapulohumeral muscular dystrophy</topic><topic>FSHD</topic><topic>FSHD2</topic><topic>Limbs</topic><topic>Magnetic resonance imaging</topic><topic>Medical imaging</topic><topic>muscle MRI</topic><topic>Muscles</topic><topic>Muscular dystrophy</topic><topic>neuromuscular diseases</topic><topic>Phenotyping</topic><topic>Resonance</topic><topic>Tau protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giacomucci, G.</creatorcontrib><creatorcontrib>Monforte, M.</creatorcontrib><creatorcontrib>Diaz‐Manera, J.</creatorcontrib><creatorcontrib>Mul, K.</creatorcontrib><creatorcontrib>Fernandez Torrón, R.</creatorcontrib><creatorcontrib>Maggi, L.</creatorcontrib><creatorcontrib>Marini Bettolo, C.</creatorcontrib><creatorcontrib>Dahlqvist, J. R.</creatorcontrib><creatorcontrib>Haberlova, J.</creatorcontrib><creatorcontrib>Camaño, P.</creatorcontrib><creatorcontrib>Gros, M.</creatorcontrib><creatorcontrib>Tartaglione, T.</creatorcontrib><creatorcontrib>Cristiano, L.</creatorcontrib><creatorcontrib>Gerevini, S.</creatorcontrib><creatorcontrib>Calandra, P.</creatorcontrib><creatorcontrib>Deidda, G.</creatorcontrib><creatorcontrib>Giardina, E.</creatorcontrib><creatorcontrib>Sacconi, S.</creatorcontrib><creatorcontrib>Straub, V.</creatorcontrib><creatorcontrib>Vissing, J.</creatorcontrib><creatorcontrib>Van Engelen, B.</creatorcontrib><creatorcontrib>Ricci, E.</creatorcontrib><creatorcontrib>Tasca, G.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giacomucci, G.</au><au>Monforte, M.</au><au>Diaz‐Manera, J.</au><au>Mul, K.</au><au>Fernandez Torrón, R.</au><au>Maggi, L.</au><au>Marini Bettolo, C.</au><au>Dahlqvist, J. R.</au><au>Haberlova, J.</au><au>Camaño, P.</au><au>Gros, M.</au><au>Tartaglione, T.</au><au>Cristiano, L.</au><au>Gerevini, S.</au><au>Calandra, P.</au><au>Deidda, G.</au><au>Giardina, E.</au><au>Sacconi, S.</au><au>Straub, V.</au><au>Vissing, J.</au><au>Van Engelen, B.</au><au>Ricci, E.</au><au>Tasca, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging</atitle><jtitle>European journal of neurology</jtitle><addtitle>Eur J Neurol</addtitle><date>2020-12</date><risdate>2020</risdate><volume>27</volume><issue>12</issue><spage>2604</spage><epage>2615</epage><pages>2604-2615</pages><issn>1351-5101</issn><eissn>1468-1331</eissn><abstract>Background and purpose The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data. Methods Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1‐weighted and short‐tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema. Results The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro‐caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2. Conclusion This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD‐related disease spectrum.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>32697863</pmid><doi>10.1111/ene.14446</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-9867-9047</orcidid><orcidid>https://orcid.org/0000-0001-6144-8544</orcidid><orcidid>https://orcid.org/0000-0003-2941-7988</orcidid><orcidid>https://orcid.org/0000-0002-4327-6969</orcidid><orcidid>https://orcid.org/0000-0003-3092-3597</orcidid><orcidid>https://orcid.org/0000-0002-8711-331X</orcidid><orcidid>https://orcid.org/0000-0002-0828-5800</orcidid><orcidid>https://orcid.org/0000-0001-8487-9478</orcidid><orcidid>https://orcid.org/0000-0002-2741-5009</orcidid><orcidid>https://orcid.org/0000-0002-4116-5579</orcidid><orcidid>https://orcid.org/0000-0002-3149-1661</orcidid><orcidid>https://orcid.org/0000-0002-0246-1455</orcidid><orcidid>https://orcid.org/0000-0003-3896-4078</orcidid><orcidid>https://orcid.org/0000-0001-6948-876X</orcidid><orcidid>https://orcid.org/0000-0002-2374-194X</orcidid><orcidid>https://orcid.org/0000-0003-0849-9144</orcidid><orcidid>https://orcid.org/0000-0001-9046-3540</orcidid><orcidid>https://orcid.org/0000-0002-2202-8165</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1351-5101
ispartof European journal of neurology, 2020-12, Vol.27 (12), p.2604-2615
issn 1351-5101
1468-1331
language eng
recordid cdi_proquest_miscellaneous_2426535864
source Wiley Journals
subjects Dystrophy
Edema
facioscapulohumeral muscular dystrophy
FSHD
FSHD2
Limbs
Magnetic resonance imaging
Medical imaging
muscle MRI
Muscles
Muscular dystrophy
neuromuscular diseases
Phenotyping
Resonance
Tau protein
title Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A53%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deep%20phenotyping%20of%20facioscapulohumeral%20muscular%20dystrophy%20type%202%20by%20magnetic%20resonance%20imaging&rft.jtitle=European%20journal%20of%20neurology&rft.au=Giacomucci,%20G.&rft.date=2020-12&rft.volume=27&rft.issue=12&rft.spage=2604&rft.epage=2615&rft.pages=2604-2615&rft.issn=1351-5101&rft.eissn=1468-1331&rft_id=info:doi/10.1111/ene.14446&rft_dat=%3Cproquest_cross%3E2458467735%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2458467735&rft_id=info:pmid/32697863&rfr_iscdi=true